Showing 1-10 of 15 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Localized immune modulation to enable long-term beta cell survival | William Marsh Rice University | Omid Veiseh | Cures | 01-September-2022 to 31-January-2026 | $600,000.00 |
| Spatial and temporal regulation of proangiogenic factors to support islet cell transplantation | William Marsh Rice University | Omid Veiseh | Cures | 01-January-2025 to 31-December-2027 | $900,000.00 |
| Immune-checkpoint engineered beta cells as treatment for T1D | UT Southwestern | Andrew Wang | Cures | 01-October-2023 to 30-September-2026 | $746,818.40 |
| Targeted delivery of therapeutics to islet beta cells for preventing and treating diabetes | UT Southwestern | Juanzhu Yan | Cures | 01-March-2025 to 29-February-2028 | $285,000.00 |
| Harnessing zinc-tropic agents for targeted delivery of therapeutics to islet beta cells for preventing or treating T1D | UT Southwestern | Wen-hong Li | Cures | 01-August-2022 to 31-October-2025 | $900,000.00 |
| Modes of action of a beta cell targeted prodrug for preventing and treating type 1 diabetes | UT Southwestern | Wen-hong Li | Cures | 01-November-2025 to 31-October-2028 | $990,000.00 |
| Can Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Mitigate Diabetic Ketoacidosis Risk? | University of Texas Health Science Center at San Antonio | Muhammad Abdul-Ghani | Improving Lives | 01-June-2019 to 31-December-2026 | $1,573,835.31 |
| MRI of Pancreas Perfusion in Response to Glucose | University of Texas at Austin | Jack Virostko | Cures | 01-July-2023 to 30-June-2025 | $179,406.56 |
| GABP regulation of human beta cell proliferation | The University of Texas Health Science Center at Houston | Richard Cox | Cures | 01-September-2024 to 31-August-2026 | $200,000.00 |
| Investigation of novel local immunomodulating strategies to enhance islet transplantation for T1D | The Methodist Hospital Research Institute | Alessandro Grattoni | Cures | 01-July-2022 to 30-June-2026 | $962,995.99 |